VAERS reports by lot

Novartis Vaccines Meningococcal lot ABX751AA: VAERS reports

25 VAERS reports list lot ABX751AA as a Novartis Vaccines Meningococcal vaccine, received between 2019-04-03 and 2019-12-06. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
25
Reports
4%
Marked serious
1
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2224%
Neurological1718%
General / Systemic (non-local)1011%
Gastrointestinal910%
Musculoskeletal910%
Respiratory89%
Cardiac / Cardiovascular78%
Allergic / Anaphylactic78%
Dermatological (non-injection-site)22%
Thrombotic / Hematological11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan5
Louisiana4
Massachusetts3
Wisconsin2
New York2
Connecticut1
Maryland1
Pennsylvania1
Ohio1
Indiana1
Nebraska1
California1

Reports by month received

2019-043
2019-053
2019-067
2019-076
2019-084
2019-111
2019-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.